APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Release Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Release Testing Market Outlook and Growth Opportunities 2026

12 August 2026214 pages

Choose your research edition.

Industry ResearchPharmaceutical Release Testing Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Release Testing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Release Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Release Testing Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Release Testing Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pharmaceutical Release Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Release Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Release Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Release Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Release Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Release Testing market include Charles River Laboratories, SGS SA, Catalent, Inc., WuXi AppTec, Intertek Group plc, Labcorp Holdings, Samsung Biologics, Lonza Group AG and Pace Analytical Life Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Release Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Release Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Release Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Release Testing market.

Pharmaceutical Release Testing Segment by Company

Charles River Laboratories

SGS SA

Catalent, Inc.

WuXi AppTec

Intertek Group plc

Labcorp Holdings

Samsung Biologics

Lonza Group AG

Pace Analytical Life Sciences

Frontage Laboratories

Curia Global

Cambrex

Alcami

Nelson Laboratories

Element Materials Technology

CMIC Holdings

Sumika Chemical Analysis Service

Tentamus Group

Syngene International

Aragen Life Sciences

RSSL

Nuvisan

Pharmaron

Eurofins Scientific SE

Thermo Fisher Scientific

Merck KGaA

Pharmaceutical Release Testing Segment by Type

Identity and Assay Testing

Purity and Impurity Testing

Potency and Bioactivity Testing

Others

Pharmaceutical Release Testing Segment by Application

Chemical Pharmaceutical Industry

Biopharmaceutical Industry

Cell and Gene Therapy Industry

Others

Pharmaceutical Release Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Release Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Release Testing key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Release Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Release Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Release Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Release Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Release Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Release Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Release Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Release Testing industry.

Chapter 3: Detailed analysis of Pharmaceutical Release Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Release Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Release Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Release Testing Industry Trends Table 2. Pharmaceutical Release Testing Industry Drivers Table 3. Pharmaceutical Release Testing Industry Opportunities and Challenges Table 4. Pharmaceutical Release Testing Industry Restraints Table 5. Global Pharmaceutical Release Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Release Testing Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Release Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Release Testing Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Release Testing Company, Product Type & Application Table 10. Global Pharmaceutical Release Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Release Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Identity and Assay Testing Table 15. Significant Companies of Purity and Impurity Testing Table 16. Significant Companies of Potency and Bioactivity Testing Table 17. Significant Companies of Others Table 18. Global Pharmaceutical Release Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical Release Testing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical Release Testing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Release Testing Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical Release Testing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Chemical Pharmaceutical Industry Table 24. Significant Companies of Biopharmaceutical Industry Table 25. Significant Companies of Cell and Gene Therapy Industry Table 26. Significant Companies of Others Table 27. Global Pharmaceutical Release Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Release Testing Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Release Testing Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Release Testing Sales Value Share by Application (2021-2026) Table 31. Global Pharmaceutical Release Testing Sales Value Share by Application (2027-2032) Table 32. Global Pharmaceutical Release Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical Release Testing Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical Release Testing Sales Value Share by Region (2021-2026) Table 35. Global Pharmaceutical Release Testing Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Pharmaceutical Release Testing Sales Value Share by Region (2027-2032) Table 37. Global Pharmaceutical Release Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmaceutical Release Testing Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Pharmaceutical Release Testing Sales Value Market Share by Country (2021-2026) Table 40. Global Pharmaceutical Release Testing Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Pharmaceutical Release Testing Sales Value Market Share by Country (2027-2032) Table 42. Charles River Laboratories Company Information Table 43. Charles River Laboratories Business Overview Table 44. Charles River Laboratories Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Charles River Laboratories Pharmaceutical Release Testing Product Portfolio Table 46. Charles River Laboratories Recent Development Table 47. SGS SA Company Information Table 48. SGS SA Business Overview Table 49. SGS SA Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. SGS SA Pharmaceutical Release Testing Product Portfolio Table 51. SGS SA Recent Development Table 52. Catalent, Inc. Company Information Table 53. Catalent, Inc. Business Overview Table 54. Catalent, Inc. Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Catalent, Inc. Pharmaceutical Release Testing Product Portfolio Table 56. Catalent, Inc. Recent Development Table 57. WuXi AppTec Company Information Table 58. WuXi AppTec Business Overview Table 59. WuXi AppTec Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. WuXi AppTec Pharmaceutical Release Testing Product Portfolio Table 61. WuXi AppTec Recent Development Table 62. Intertek Group plc Company Information Table 63. Intertek Group plc Business Overview Table 64. Intertek Group plc Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Intertek Group plc Pharmaceutical Release Testing Product Portfolio Table 66. Intertek Group plc Recent Development Table 67. Labcorp Holdings Company Information Table 68. Labcorp Holdings Business Overview Table 69. Labcorp Holdings Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Labcorp Holdings Pharmaceutical Release Testing Product Portfolio Table 71. Labcorp Holdings Recent Development Table 72. Samsung Biologics Company Information Table 73. Samsung Biologics Business Overview Table 74. Samsung Biologics Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Samsung Biologics Pharmaceutical Release Testing Product Portfolio Table 76. Samsung Biologics Recent Development Table 77. Lonza Group AG Company Information Table 78. Lonza Group AG Business Overview Table 79. Lonza Group AG Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Lonza Group AG Pharmaceutical Release Testing Product Portfolio Table 81. Lonza Group AG Recent Development Table 82. Pace Analytical Life Sciences Company Information Table 83. Pace Analytical Life Sciences Business Overview Table 84. Pace Analytical Life Sciences Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pace Analytical Life Sciences Pharmaceutical Release Testing Product Portfolio Table 86. Pace Analytical Life Sciences Recent Development Table 87. Frontage Laboratories Company Information Table 88. Frontage Laboratories Business Overview Table 89. Frontage Laboratories Pharmaceutical Release Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Frontage Laboratories Pharmaceutical Release Testing Product Portfolio Table 91. Frontage Laboratories Recent Development Table 92. Curia Global Company Information Table 93. Curia Global Business Overview Table 94. Curia Global Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Curia Global Pharmaceutical Release Testing Product Portfolio Table 96. Curia Global Recent Development Table 97. Cambrex Company Information Table 98. Cambrex Business Overview Table 99. Cambrex Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Cambrex Pharmaceutical Release Testing Product Portfolio Table 101. Cambrex Recent Development Table 102. Alcami Company Information Table 103. Alcami Business Overview Table 104. Alcami Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Alcami Pharmaceutical Release Testing Product Portfolio Table 106. Alcami Recent Development Table 107. Nelson Laboratories Company Information Table 108. Nelson Laboratories Business Overview Table 109. Nelson Laboratories Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Nelson Laboratories Pharmaceutical Release Testing Product Portfolio Table 111. Nelson Laboratories Recent Development Table 112. Element Materials Technology Company Information Table 113. Element Materials Technology Business Overview Table 114. Element Materials Technology Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Element Materials Technology Pharmaceutical Release Testing Product Portfolio Table 116. Element Materials Technology Recent Development Table 117. CMIC Holdings Company Information Table 118. CMIC Holdings Business Overview Table 119. CMIC Holdings Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. CMIC Holdings Pharmaceutical Release Testing Product Portfolio Table 121. CMIC Holdings Recent Development Table 122. Sumika Chemical Analysis Service Company Information Table 123. Sumika Chemical Analysis Service Business Overview Table 124. Sumika Chemical Analysis Service Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Sumika Chemical Analysis Service Pharmaceutical Release Testing Product Portfolio Table 126. Sumika Chemical Analysis Service Recent Development Table 127. Tentamus Group Company Information Table 128. Tentamus Group Business Overview Table 129. Tentamus Group Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Tentamus Group Pharmaceutical Release Testing Product Portfolio Table 131. Tentamus Group Recent Development Table 132. Syngene International Company Information Table 133. Syngene International Business Overview Table 134. Syngene International Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Syngene International Pharmaceutical Release Testing Product Portfolio Table 136. Syngene International Recent Development Table 137. Aragen Life Sciences Company Information Table 138. Aragen Life Sciences Business Overview Table 139. Aragen Life Sciences Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Aragen Life Sciences Pharmaceutical Release Testing Product Portfolio Table 141. Aragen Life Sciences Recent Development Table 142. RSSL Company Information Table 143. RSSL Business Overview Table 144. RSSL Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. RSSL Pharmaceutical Release Testing Product Portfolio Table 146. RSSL Recent Development Table 147. Nuvisan Company Information Table 148. Nuvisan Business Overview Table 149. Nuvisan Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Nuvisan Pharmaceutical Release Testing Product Portfolio Table 151. Nuvisan Recent Development Table 152. Pharmaron Company Information Table 153. Pharmaron Business Overview Table 154. Pharmaron Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Pharmaron Pharmaceutical Release Testing Product Portfolio Table 156. Pharmaron Recent Development Table 157. Eurofins Scientific SE Company Information Table 158. Eurofins Scientific SE Business Overview Table 159. Eurofins Scientific SE Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Eurofins Scientific SE Pharmaceutical Release Testing Product Portfolio Table 161. Eurofins Scientific SE Recent Development Table 162. Thermo Fisher Scientific Company Information Table 163. Thermo Fisher Scientific Business Overview Table 164. Thermo Fisher Scientific Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Thermo Fisher Scientific Pharmaceutical Release Testing Product Portfolio Table 166. Thermo Fisher Scientific Recent Development Table 167. Merck KGaA Company Information Table 168. Merck KGaA Business Overview Table 169. Merck KGaA Pharmaceutical Release Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Merck KGaA Pharmaceutical Release Testing Product Portfolio Table 171. Merck KGaA Recent Development Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Pharmaceutical Release Testing Product Image Figure 2. Global Pharmaceutical Release Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Release Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Release Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Identity and Assay Testing Image Figure 8. Purity and Impurity Testing Image Figure 9. Potency and Bioactivity Testing Image Figure 10. Others Image Figure 11. Global Pharmaceutical Release Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Release Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Release Testing Sales Value Share by Type (2021-2032) Figure 14. Chemical Pharmaceutical Industry Image Figure 15. Biopharmaceutical Industry Image Figure 16. Cell and Gene Therapy Industry Image Figure 17. Others Image Figure 18. Global Pharmaceutical Release Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Release Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Release Testing Sales Value Share by Application (2021-2032) Figure 21. Global Pharmaceutical Release Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pharmaceutical Release Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Pharmaceutical Release Testing Sales Value (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical Release Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Pharmaceutical Release Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Pharmaceutical Release Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Pharmaceutical Release Testing Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Pharmaceutical Release Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Pharmaceutical Release Testing Sales Value (2021-2032) & (US$ Million) Figure 30. South America Pharmaceutical Release Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Pharmaceutical Release Testing Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Pharmaceutical Release Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Identity and Assay Testing
  • Purity and Impurity Testing
  • Potency and Bioactivity Testing
  • Others
Applications
  • Chemical Pharmaceutical Industry
  • Biopharmaceutical Industry
  • Cell and Gene Therapy Industry
  • Others
Companies covered
  • Charles River Laboratories
  • SGS SA
  • Catalent, Inc.
  • WuXi AppTec
  • Intertek Group plc
  • Labcorp Holdings
  • Samsung Biologics
  • Lonza Group AG
  • Pace Analytical Life Sciences
  • Frontage Laboratories
  • Curia Global
  • Cambrex
  • Alcami
  • Nelson Laboratories
  • Element Materials Technology
  • CMIC Holdings
  • Sumika Chemical Analysis Service
  • Tentamus Group
  • Syngene International
  • Aragen Life Sciences
  • RSSL
  • Nuvisan
  • Pharmaron
  • Eurofins Scientific SE
  • Thermo Fisher Scientific
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Release Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Release Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Release Testing Market Dynamics
  1. 2.1 Pharmaceutical Release Testing Industry Trends
  2. 2.2 Pharmaceutical Release Testing Industry Drivers
  3. 2.3 Pharmaceutical Release Testing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Release Testing Industry Restraints
3 Pharmaceutical Release Testing Market by Company
  1. 3.1 Global Pharmaceutical Release Testing Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Release Testing Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Release Testing Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Release Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Release Testing Company Product Type and Application
  6. 3.6 Global Pharmaceutical Release Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Release Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Release Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Release Testing Market by Type
  1. 4.1 Pharmaceutical Release Testing Type Introduction
  2. 4.1.1 Identity and Assay Testing
  3. 4.1.2 Purity and Impurity Testing
  4. 4.1.3 Potency and Bioactivity Testing
  5. 4.1.4 Others
  6. 4.2 Global Pharmaceutical Release Testing Sales Value by Type
  7. 4.2.1 Global Pharmaceutical Release Testing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Release Testing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Release Testing Sales Value Share by Type (2021-2032)
5 Pharmaceutical Release Testing Market by Application
  1. 5.1 Pharmaceutical Release Testing Application Introduction
  2. 5.1.1 Chemical Pharmaceutical Industry
  3. 5.1.2 Biopharmaceutical Industry
  4. 5.1.3 Cell and Gene Therapy Industry
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Release Testing Sales Value by Application
  7. 5.2.1 Global Pharmaceutical Release Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Release Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Release Testing Sales Value Share by Application (2021-2032)
6 Pharmaceutical Release Testing Regional Value Analysis
  1. 6.1 Global Pharmaceutical Release Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Release Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Release Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Release Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Release Testing Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Release Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Release Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Release Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Release Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Release Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Release Testing Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Release Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Release Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Release Testing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Release Testing Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Release Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Release Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Release Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Release Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Release Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Release Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Release Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River Laboratories
  2. 8.1.1 Charles River Laboratories Company Information
  3. 8.1.2 Charles River Laboratories Business Overview
  4. 8.1.3 Charles River Laboratories Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Laboratories Pharmaceutical Release Testing Product Portfolio
  6. 8.1.5 Charles River Laboratories Recent Developments
  7. 8.2 SGS SA
  8. 8.2.1 SGS SA Company Information
  9. 8.2.2 SGS SA Business Overview
  10. 8.2.3 SGS SA Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SGS SA Pharmaceutical Release Testing Product Portfolio
  12. 8.2.5 SGS SA Recent Developments
  13. 8.3 Catalent, Inc.
  14. 8.3.1 Catalent, Inc. Company Information
  15. 8.3.2 Catalent, Inc. Business Overview
  16. 8.3.3 Catalent, Inc. Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Catalent, Inc. Pharmaceutical Release Testing Product Portfolio
  18. 8.3.5 Catalent, Inc. Recent Developments
  19. 8.4 WuXi AppTec
  20. 8.4.1 WuXi AppTec Company Information
  21. 8.4.2 WuXi AppTec Business Overview
  22. 8.4.3 WuXi AppTec Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 WuXi AppTec Pharmaceutical Release Testing Product Portfolio
  24. 8.4.5 WuXi AppTec Recent Developments
  25. 8.5 Intertek Group plc
  26. 8.5.1 Intertek Group plc Company Information
  27. 8.5.2 Intertek Group plc Business Overview
  28. 8.5.3 Intertek Group plc Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Intertek Group plc Pharmaceutical Release Testing Product Portfolio
  30. 8.5.5 Intertek Group plc Recent Developments
  31. 8.6 Labcorp Holdings
  32. 8.6.1 Labcorp Holdings Company Information
  33. 8.6.2 Labcorp Holdings Business Overview
  34. 8.6.3 Labcorp Holdings Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Labcorp Holdings Pharmaceutical Release Testing Product Portfolio
  36. 8.6.5 Labcorp Holdings Recent Developments
  37. 8.7 Samsung Biologics
  38. 8.7.1 Samsung Biologics Company Information
  39. 8.7.2 Samsung Biologics Business Overview
  40. 8.7.3 Samsung Biologics Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Samsung Biologics Pharmaceutical Release Testing Product Portfolio
  42. 8.7.5 Samsung Biologics Recent Developments
  43. 8.8 Lonza Group AG
  44. 8.8.1 Lonza Group AG Company Information
  45. 8.8.2 Lonza Group AG Business Overview
  46. 8.8.3 Lonza Group AG Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lonza Group AG Pharmaceutical Release Testing Product Portfolio
  48. 8.8.5 Lonza Group AG Recent Developments
  49. 8.9 Pace Analytical Life Sciences
  50. 8.9.1 Pace Analytical Life Sciences Company Information
  51. 8.9.2 Pace Analytical Life Sciences Business Overview
  52. 8.9.3 Pace Analytical Life Sciences Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pace Analytical Life Sciences Pharmaceutical Release Testing Product Portfolio
  54. 8.9.5 Pace Analytical Life Sciences Recent Developments
  55. 8.10 Frontage Laboratories
  56. 8.10.1 Frontage Laboratories Company Information
  57. 8.10.2 Frontage Laboratories Business Overview
  58. 8.10.3 Frontage Laboratories Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Frontage Laboratories Pharmaceutical Release Testing Product Portfolio
  60. 8.10.5 Frontage Laboratories Recent Developments
  61. 8.11 Curia Global
  62. 8.11.1 Curia Global Company Information
  63. 8.11.2 Curia Global Business Overview
  64. 8.11.3 Curia Global Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Curia Global Pharmaceutical Release Testing Product Portfolio
  66. 8.11.5 Curia Global Recent Developments
  67. 8.12 Cambrex
  68. 8.12.1 Cambrex Company Information
  69. 8.12.2 Cambrex Business Overview
  70. 8.12.3 Cambrex Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cambrex Pharmaceutical Release Testing Product Portfolio
  72. 8.12.5 Cambrex Recent Developments
  73. 8.13 Alcami
  74. 8.13.1 Alcami Company Information
  75. 8.13.2 Alcami Business Overview
  76. 8.13.3 Alcami Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Alcami Pharmaceutical Release Testing Product Portfolio
  78. 8.13.5 Alcami Recent Developments
  79. 8.14 Nelson Laboratories
  80. 8.14.1 Nelson Laboratories Company Information
  81. 8.14.2 Nelson Laboratories Business Overview
  82. 8.14.3 Nelson Laboratories Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Nelson Laboratories Pharmaceutical Release Testing Product Portfolio
  84. 8.14.5 Nelson Laboratories Recent Developments
  85. 8.15 Element Materials Technology
  86. 8.15.1 Element Materials Technology Company Information
  87. 8.15.2 Element Materials Technology Business Overview
  88. 8.15.3 Element Materials Technology Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Element Materials Technology Pharmaceutical Release Testing Product Portfolio
  90. 8.15.5 Element Materials Technology Recent Developments
  91. 8.16 CMIC Holdings
  92. 8.16.1 CMIC Holdings Company Information
  93. 8.16.2 CMIC Holdings Business Overview
  94. 8.16.3 CMIC Holdings Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CMIC Holdings Pharmaceutical Release Testing Product Portfolio
  96. 8.16.5 CMIC Holdings Recent Developments
  97. 8.17 Sumika Chemical Analysis Service
  98. 8.17.1 Sumika Chemical Analysis Service Company Information
  99. 8.17.2 Sumika Chemical Analysis Service Business Overview
  100. 8.17.3 Sumika Chemical Analysis Service Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sumika Chemical Analysis Service Pharmaceutical Release Testing Product Portfolio
  102. 8.17.5 Sumika Chemical Analysis Service Recent Developments
  103. 8.18 Tentamus Group
  104. 8.18.1 Tentamus Group Company Information
  105. 8.18.2 Tentamus Group Business Overview
  106. 8.18.3 Tentamus Group Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Tentamus Group Pharmaceutical Release Testing Product Portfolio
  108. 8.18.5 Tentamus Group Recent Developments
  109. 8.19 Syngene International
  110. 8.19.1 Syngene International Company Information
  111. 8.19.2 Syngene International Business Overview
  112. 8.19.3 Syngene International Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Syngene International Pharmaceutical Release Testing Product Portfolio
  114. 8.19.5 Syngene International Recent Developments
  115. 8.20 Aragen Life Sciences
  116. 8.20.1 Aragen Life Sciences Company Information
  117. 8.20.2 Aragen Life Sciences Business Overview
  118. 8.20.3 Aragen Life Sciences Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Aragen Life Sciences Pharmaceutical Release Testing Product Portfolio
  120. 8.20.5 Aragen Life Sciences Recent Developments
  121. 8.21 RSSL
  122. 8.21.1 RSSL Company Information
  123. 8.21.2 RSSL Business Overview
  124. 8.21.3 RSSL Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 RSSL Pharmaceutical Release Testing Product Portfolio
  126. 8.21.5 RSSL Recent Developments
  127. 8.22 Nuvisan
  128. 8.22.1 Nuvisan Company Information
  129. 8.22.2 Nuvisan Business Overview
  130. 8.22.3 Nuvisan Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Nuvisan Pharmaceutical Release Testing Product Portfolio
  132. 8.22.5 Nuvisan Recent Developments
  133. 8.23 Pharmaron
  134. 8.23.1 Pharmaron Company Information
  135. 8.23.2 Pharmaron Business Overview
  136. 8.23.3 Pharmaron Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Pharmaron Pharmaceutical Release Testing Product Portfolio
  138. 8.23.5 Pharmaron Recent Developments
  139. 8.24 Eurofins Scientific SE
  140. 8.24.1 Eurofins Scientific SE Company Information
  141. 8.24.2 Eurofins Scientific SE Business Overview
  142. 8.24.3 Eurofins Scientific SE Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Eurofins Scientific SE Pharmaceutical Release Testing Product Portfolio
  144. 8.24.5 Eurofins Scientific SE Recent Developments
  145. 8.25 Thermo Fisher Scientific
  146. 8.25.1 Thermo Fisher Scientific Company Information
  147. 8.25.2 Thermo Fisher Scientific Business Overview
  148. 8.25.3 Thermo Fisher Scientific Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Thermo Fisher Scientific Pharmaceutical Release Testing Product Portfolio
  150. 8.25.5 Thermo Fisher Scientific Recent Developments
  151. 8.26 Merck KGaA
  152. 8.26.1 Merck KGaA Company Information
  153. 8.26.2 Merck KGaA Business Overview
  154. 8.26.3 Merck KGaA Pharmaceutical Release Testing Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Merck KGaA Pharmaceutical Release Testing Product Portfolio
  156. 8.26.5 Merck KGaA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst